SCHEMBL17848232

SCHEMBL17848232

O=C(O)CNC(=O)c1ccc2nc(N3[C@@H]4CC[C@H]3C[C@@H](OCc3c(-c5ccccc5OC(F)(F)F)noc3C3CC3)C4)sc2c1

nearest known ligand 0.84

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ NR1H4 Q96RI1 19/20 0.84
▸ FXR2 P51116 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10263154 1.00 NR1H4 (0.84) NR1H4FXR2
SCHEMBL17145988 1.00 NR1H4 (0.84) NR1H4FXR2
SCHEMBL17145987 0.94 NR1H4 (0.81) NR1H4
SCHEMBL9955743 0.94 NR1H4 (0.81) NR1H4
SCHEMBL20833699 0.93 NR1H4 (0.74) NR1H4FXR2
SCHEMBL17128505 0.92 NR1H4 (1.00) NR1H4FXR2
SCHEMBL17128508 0.92 NR1H4 (1.00) NR1H4FXR2
SCHEMBL9958227 0.92 NR1H4 (1.00) NR1H4FXR2
SCHEMBL19739533 0.92 NR1H4 (1.00) NR1H4FXR2
SCHEMBL17861443 0.92 NR1H4 (1.00) NR1H4FXR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233083-A1 AZABICYCLOOCTANE DERIVATIVES AS FXR AGONISTS FOR USE IN THE TREATMENT OF LIVER AND GASTROINTESTINAL DISEASES Novartis AG (CH) 2017-10-25 — — EP disclosed
WO-2016097933-A1 AZABICYCLOOCTANE DERIVATIVES AS FXR AGONISTS FOR USE IN THE TREATMENT OF LIVER AND GASTROINTESTINAL DISEASES NOVARTIS AG (CH) 2016-06-23 — — WO disclosed
Send feedback